Trial intelligence / Profile preview

KING: Ketorolac Dosing for Post-cesarean Pain Management

NCT05248984Phase 4Completed

Sponsor
The Ohio State University
Start
Jun 2022
Primary completion
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ketorolac in postoperative pain, sponsored by The Ohio State University. Started Jun 2022; status: completed.

02

Drugs

ketorolac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05248984.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05248984.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call